Poised for Success: Implementation of Sound Conditioning Strategies to Promote Endogenous Protective Responses to Stroke in Patients

Translational Stroke Research

Volumn 4, Issue 1, 2013, Pages 104-113

  McLaughlin, BethAnn ^a   Gidday, Jeff M ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Hypoxia; Ischemia; Meeting; Neuroprotection; Perconditioning; Postconditioning; Preconditioning; Proceedings; Stroke; Translational stroke

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR ACCIDENT; COMORBIDITY; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SOUND; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

BIOMARKERS, PHARMACOLOGICAL; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROPROTECTIVE AGENTS; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84872672864     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0240-3     Document Type: Article

References (49)

1. Mergenthaler P, Dirnagl U. Protective conditioning of the brain: expressway or roadblock? The Journal of Physiology. 2011; 589(17): 4147-55.
2. Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage. Stroke. 2011; 42(5): 1387-91.
3. Keep M, Elmer E, Fong K, Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res. 2001; 894: 327.
4. Zhang Y, Park TS, Gidday JM. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Americal Journal of Physiology Heart Circulation Physiology. 2007; 292(6): H2573-81.
5. Behl C, Holsboer F. Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection. Fortschritte Der Neurologie-Psychiatrie. 1998; 66(3): 113-21.
6. Jensen HA, Loukogeorgakis S, Yannopoulos F, Rimpiläinen E, Petzold A, Tuominen H, et al. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest/clinical perspective. Circulation. 2011; 123(7): 714-21.
7. Lyden PD, Lees KR, Davis SM. Alteplase for acute stroke revisited: the first 10 years. The Lancet Neurology. 2006; 5(9): 722.
8. Fisher M, for the Stroke Therapy Academic Industry Roundtable IV. Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable. Stroke. 2005; 36(8): 1808-13.
9. Lapchak P, Zhang J, Noble-Haeusslein L. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Translational Stroke Research. 2012. doi: 10. 1007/s12975-012-0209-2.
10. Kitano H, Young J, Cheng J, Wang L, Hurn PD, Murphy SJ. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. 2007; 27: 1377-86.
11. Bickler PE, Fahlman CS. Enhanced hypoxic preconditioning by isoflurane: signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptors. Brain Res. 2010; 1340(20434434): 86-95.
12. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012; 490(7419): 187-91.
13. Lefer DJ, Bolli R. Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): a paradigm shift in studies of infarct size limitation. Journal of Cardiovascular Pharmacology and Therapeutics. 2011; 16(3-4): 332-9.
14. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase c and protein tyrosine kinase in pigs. Journal of Molecular and Cellular Cardiology. 1998; 30(2): 197-209.
15. Hoda MN, Siddiqui S, Herberg S, Periyasamy-Thandavan S, Bhatia K, Hafez SS, et al. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 2012; 21: 2012.
16. Nowak TS, Zhao L. Conditioning studies in focal cerebral ischemia: model selection, physiological monitoring, and other methodological issues. Springer Series in Translational Stroke Research. 2013. doi: 10. 1007/978-1-4419-9695-4_13.
17. Johnston SC, Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA study. Stroke. 2004; 35(11_suppl_1): 2680-2.
18. Huang DT, Walden H, Duda D, Schulman BA. Ubiquitin-like protein activation. Oncogene. 2004; 23(11): 1958-71.
19. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, et al. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab. 2005; 25: 234.
20. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. The Lancet. 2003; 362(9389): 1028-37.
21. McLaughlin BA, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, et al. Caspase 3 activation is essential for neuroprotection in ischemic preconditioning. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(2): 715-20.
22. Yellon DM, Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res. 2000; 87(7): 543-50.
23. Gidday JM, B. K. McMahan, Y. Zhu. Long-lasting neuroprotection induced in mouse retina by repeated hypoxic preconditioning. Invest Ophthalmol Vis Sci 2003; (Program #2942).
24. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, et al. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radical Biology and Medicine. 2005; 38(6): 711-8.
25. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, et al. Biomarkers of oxidative stress study II. Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radical Biology and Medicine. 2005; 38(6): 698-710.
26. Goldemund D, Mikulik R. Reperfusion therapies for acute ischemic stroke. Current Treatment Options in Neurology. 2010; 12(2): 155-66.
27. Abou-Chebl A. Intra-arterial therapy for acute ischemic stroke. Neurotherapeutics. 2011; 8(3): 400-13.
28. Furlan AJ. Clot retrieval for stroke should be restricted to clinical trials no. Stroke. 2010; 41(1): 194-5.
29. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. Stroke. 2011; 42(1): 227-76.
30. Della Morte D, Abete P, Gallucci F, Scaglione A, D'Ambrosio D, Gargiulo G, et al. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. Journal of Stroke and Cerebrovascular Diseases. 2008; 17(5): 257-62.
31. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003; 26(5): 248-54.
32. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology. 2000; 54(11): 2089-94.
33. McLaughlin BA, Kirshner H. Wagging the dog-moving closer to features defined by basic scientists, the protection of prodromal transient ischaemic attacks reveals itself. European Journal Of Neurology. 2008; 15(8): 755-6.
34. O'Duffy AE, Bordelon YM, McLaughlin B. Killer proteases and little strokes-how the things that do not kill you make you stronger. Journal of Cerebral Blood Flow and Metabolism. 2007; 27(4): 655-68.
35. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke. 1999; 30(9): 1851-4.
36. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke. 2004; 35(3): 616-21.
37. Kissela BM, Khoury J, Alwell K, Miller R, Ewing I, Kleindorfer D, Kissela BM, Khoury J, Alwell K, Miller R, Ewing I, Kleindorfer D, et al. Long term mortality after ischemic stroke: the effect of diabetes in the greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS). Stroke. 2004; 35(1): 315.
38. Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke. 2002; 33(8): 1981-5.
39. Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Neuroprotection for ischaemic stroke: translation from the bench to the bedside. International Journal of Stroke. 2012; 7(5): 407-18.
40. Gonzalez NR, Liebeskind DS. Letter by Gonzalez and Liebeskind regarding article, "Remote ischemic limb preconditioning after subarachnoid hemorrhage: a Phase Ib study of safety and feasibility". Stroke. 2011; 42(9): e553.
41. Meng R, Asmaro K, Meng L, Liu Y, Ma C, Xi C, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012; 79(18): 1853-61.
42. Davies SS, Traustadóttir T, Stock AA, Ye F, Shyr Y, Harman SM, et al. Ischemia/reperfusion unveils impaired capacity of older adults to restrain oxidative insult. Free Radical Biology and Medicine. 2009; 47(7): 1014-8.
43. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth. 2003; 91(4): 551-65.
44. de Leciñana MA, Fuentes B, Masjuan J, Simal P, Díaz-Otero F, Reig G, et al. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack. International Journal of Stroke. 2012; 7(3): 213-8.
45. Veighey K, MacAllister RJ. Clinical applications of remote ischemic preconditioning. Cardiology Research and Practice. 2012; 2012: 9.
46. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 2012; 59(24): 2175-81.
47. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, et al. Long-term benefit of postconditioning. Circulation. 2008; 117(8): 1037-44.
48. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010; 375(20189026): 727-34.
49. Ludman AJ, Yellon DM, Hausenloy DJ. Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech. 2010; 3(1-2): 35-8.